A citation-based method for searching scientific literature

Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
Times Cited: 117







List of co-cited articles
772 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
690
76

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
637
76

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
757
75

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
66

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
50

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Francesco Sardanelli, Franca Podo, Giuliano D'Agnolo, Arduino Verdecchia, Mariano Santaquilani, Renato Musumeci, Giovanna Trecate, Siranoush Manoukian, Sandro Morassut, Clelia de Giacomi,[...]. Radiology 2007
239
38

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
323
32

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
257
31

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Constance D Lehman, Jeffrey D Blume, Paul Weatherall, David Thickman, Nola Hylton, Ellen Warner, Etta Pisano, Stuart J Schnitt, Constantine Gatsonis, Mitchell Schnall,[...]. Cancer 2005
258
30

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.
Constance D Lehman, Claudine Isaacs, Mitchell D Schnall, Etta D Pisano, Susan M Ascher, Paul T Weatherall, David A Bluemke, Deborah J Bowen, P Kelly Marcom, Deborah K Armstrong,[...]. Radiology 2007
238
26

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
192
26

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Sylvia K Plevritis, Allison W Kurian, Bronislava M Sigal, Bruce L Daniel, Debra M Ikeda, Frank E Stockdale, Alan M Garber. JAMA 2006
174
23

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
111
23

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
155
21

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Christiane K Kuhl, Simone Schrading, Heribert B Bieling, Eva Wardelmann, Claudia C Leutner, Roy Koenig, Walther Kuhn, Hans H Schild. Lancet 2007
420
18

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
405
18

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.
C T Brekelmans, C Seynaeve, C C Bartels, M M Tilanus-Linthorst, E J Meijers-Heijboer, C M Crepin, A A van Geel, M Menke, L C Verhoog, A van den Ouweland,[...]. J Clin Oncol 2001
225
17

BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials.
Madeleine M A Tilanus-Linthorst, Inge-Marie Obdeijn, Wim C J Hop, Petrina A Causer, Martin O Leach, Ellen Warner, Linda Pointon, Kimberley Hill, Jan G M Klijn, Ruth M L Warren,[...]. Clin Cancer Res 2007
68
23

Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
E Warner, D B Plewes, R S Shumak, G C Catzavelos, L S Di Prospero, M J Yaffe, V Goel, E Ramsay, P L Chart, D E Cole,[...]. J Clin Oncol 2001
311
16

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
Wendie A Berg, Jeffrey D Blume, Jean B Cormack, Ellen B Mendelson, Daniel Lehrer, Marcela Böhm-Vélez, Etta D Pisano, Roberta A Jong, W Phil Evans, Marilyn J Morton,[...]. JAMA 2008
800
15

Diagnostic performance of digital versus film mammography for breast-cancer screening.
Etta D Pisano, Constantine Gatsonis, Edward Hendrick, Martin Yaffe, Janet K Baum, Suddhasatta Acharyya, Emily F Conant, Laurie L Fajardo, Lawrence Bassett, Carl D'Orsi,[...]. N Engl J Med 2005
15

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
107
15

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
14

Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Christopher C Riedl, Lothar Ponhold, Daniel Flöry, Michael Weber, Regina Kroiss, Teresa Wagner, Michael Fuchsjäger, Thomas H Helbich. Clin Cancer Res 2007
67
20

Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
Charu Taneja, John Edelsberg, Derek Weycker, Amy Guo, Gerry Oster, Jeffrey Weinreb. J Am Coll Radiol 2009
60
23

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
I Griebsch, J Brown, C Boggis, A Dixon, M Dixon, D Easton, R Eeles, D G Evans, F J Gilbert, J Hawnaur,[...]. Br J Cancer 2006
80
17

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.
Madeleine Tilanus-Linthorst, Leon Verhoog, Inge-Marie Obdeijn, Karina Bartels, Marian Menke-Pluymers, Alexander Eggermont, Jan Klijn, Hanne Meijers-Heijboer, Theo van der Kwast, Cecile Brekelmans. Int J Cancer 2002
126
13


Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
152
13

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Wendie A Berg, Lorena Gutierrez, Moriel S NessAiver, W Bradford Carter, Mythreyi Bhargavan, Rebecca S Lewis, Olga B Ioffe. Radiology 2004
852
12

MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.
Constance D Lehman, Constantine Gatsonis, Christiane K Kuhl, R Edward Hendrick, Etta D Pisano, Lucy Hanna, Sue Peacock, Stanley F Smazal, Daniel D Maki, Thomas B Julian,[...]. N Engl J Med 2007
579
12

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Anne-Renee Hartman, Bruce L Daniel, Allison W Kurian, Meredith A Mills, Kent W Nowels, Frederick M Dirbas, Kerry E Kingham, Nicki M Chun, Robert J Herfkens, James M Ford,[...]. Cancer 2004
58
20

Multimodality screening of high-risk women: a prospective cohort study.
Susan P Weinstein, A Russell Localio, Emily F Conant, Mark Rosen, Kathleen M Thomas, Mitchell D Schnall. J Clin Oncol 2009
69
17

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
550
12

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
73
16

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
241
11

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
697
11

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Sara H Muller, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Emiel J T Rutgers, Harry J de Koning,[...]. Cancer 2006
54
20


Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
Janie M Lee, Pamela M McMahon, Chung Y Kong, Daniel B Kopans, Paula D Ryan, Elissa M Ozanne, Elkan F Halpern, G Scott Gazelle. Radiology 2010
42
26

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
11

Breast MRI screening of women with a personal history of breast cancer.
Sandra Brennan, Laura Liberman, D David Dershaw, Elizabeth Morris. AJR Am J Roentgenol 2010
102
11

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
131
11

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
C K Kuhl, R K Schmutzler, C C Leutner, A Kempe, E Wardelmann, A Hocke, M Maringa, U Pfeifer, D Krebs, H H Schild. Radiology 2000
395
10

Mammographic, US, and MR imaging phenotypes of familial breast cancer.
Simone Schrading, Christiane K Kuhl. Radiology 2008
121
10

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
651
10

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
476
10

Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.
Francesco Sardanelli, Gian M Giuseppetti, Pietro Panizza, Massimo Bazzocchi, Alfonso Fausto, Giovanni Simonetti, Vincenzo Lattanzio, Alessandro Del Maschio. AJR Am J Roentgenol 2004
284
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.